HHS
Regulatory Reform Committee Holds First Meeting
January 11, 2002 - The Department of Health and Human
Services Secretary's Advisory Committee on Regulatory Reform
held its first meeting on Jan. 7-8. The Committee is part
of a new Department-wide initiative to streamline regulatory
procedures, particularly in the Centers for Medicare & Medicaid
Services (CMS) and the Food and Drug Administration (FDA).
It is charged with assisting Secretary Tommy Thompson to "streamline
burdensome, inefficient regulations that interfere with the
quality of health care for Americans." Its underlying objectives
are to concentrate on issues where practical changes can be
made to improve the quality of care for large numbers of patients,
and solicit comments from the public to gather insight from
all stakeholders. Douglas Wood, M.D., a cardiologist from
the Mayo Clinic, chairs the Committee.
The Committee will focus on four general areas: health
care delivery, health systems operations, biomedical and
health research, and the development of pharmaceuticals
and other products. Due to the breadth of topics and sheer
size of the committee, subcommittees have been developed
to explore issues more comprehensively and effectively,
and will report their recommendations to the full committee.
Over the next year, the committee is scheduled to meet
three times unless the Secretary determines that additional
meetings are necessary. In addition, committee members will
conduct field hearings across the country. The input and
advice compiled at these hearing will help guide the committee
to develop suggestions for reform. Approximately 30 days
following each meeting, the committee will present its findings
in the form of a written report, and a final report is expected
to be issued in the fall.
Additional information, including membership and scheduling
is available on the Department's Regulatory
Reform Web site. The Department also issued a notice
in the Jan. 4 Federal Register [67
FR 599] soliciting formal public comments to the Committee.
Comments are due by March 5 and are limited to 5 single-spaced
pages. They should be sent to Christy Schmidt, Executive
Coordinator, Regulatory Reform Initiative, Office of the
Assistant Secretary for Planning and Evaluation, 200 Independence
Ave., SW, Washington, DC 20201, or submitted electronically
via the Web site listed above.
Information:
CMS Regulations: Ivy Baer, Director & Regulatory Counsel
AAMC Health Care Affairs
ibaer@aamc.orc
(202) 828-0490 |
FDA Regulations: [an error occurred while processing this directive] |

Get Washington Highlights
in your Inbox!
|